The 'big three' insulin producers Novo Nordisk ... including Hispanic and Black people, who are much more likely to be diagnosed with diabetes than non-Hispanic white people - and much more ...
Meanwhile Novo Nordisk has also seen its ranking surge ... Download the Productive Innovation Index white paper here. About the author: Andrew McConaghie is pharmaphorum's managing editor, feature ...
As part of NJBIZ’s latest virtual discussion, business leaders in New Jersey weighed in on what to expect in the first 100 ...
Citigroup wins appeal against military personnel over credit card rates Legalcategory· January 27, 2025 Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney ...
10x, Harvard settle genomics patent dispute with Vizgen during trial February 6, 2025 Novo Nordisk defended its ... established to boost the pipeline of Black, Latino and Native American people ...
Novo Nordisk's CEO took a $1.5 million pay cut in 2024 as the pharma giant's share price tanked and it missed profit and DEI ...
Morgan Stanley initiated coverage of Novo Nordisk (NVO) with an Equal Weight rating and DKK 700 price target The firm says near-term U.S.
New York, New York-- (Newsfile Corp. - February 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Novo Nordisk (NYSE: NVO) and certain ...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Novo Nordisk A/S Bagsværd, Denmark, 6 February 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives ...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 7 February 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their ...
Morgan Stanley (NYSE:MS) initiated coverage on shares of Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), a global healthcare company specializing in diabetes care and other serious chronic conditions. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results